59813-07-9

Basic information

• Product Name: piperazine monohydrobromide
• CAS NO: 59813-07-9
• Molecular Weight: 167.049
• Mol File: 59813-07-9.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: piperazine monohydrobromide(CAS DataBase Reference)
• NIST Chemistry Reference: piperazine monohydrobromide(59813-07-9)
• EPA Substance Registry System: piperazine monohydrobromide(59813-07-9)

Safety Data

• Hazardous Substances Data: 59813-07-9(Hazardous Substances Data)

Upstream product

• 110-85-0 piperazine 
• 120952-09-2 2-bromo-N-ethylpyridinium tetraphenylborate 
• 724788-70-9 8-bromo-7-fluoro-2-methoxy-1,5-naphthyridine 
• 79343-93-4 1-ethyl-2-bromo-pyridinium; bromide 

Downstream Products

• 124953-36-2 (3-Benzyloxy-isoxazol-5-yl)-piperazin-1-yl-methanone 
• 124953-38-4 1-[(5-methyl-3-phenyl-4-isoxazolyl)carbonyl]-piperazine 
• 124953-47-5 4-(5-Methyl-3-phenyl-isoxazole-4-carbonyl)-piperazine-1-carbothioic acid (2-cyano-4,5-dimethoxy-phenyl)-amide 
• 124953-49-7 4-[3-(3-Bromo-isoxazol-5-yl)-propionyl]-piperazine-1-carbothioic acid (2-cyano-4,5-dimethoxy-phenyl)-amide 
• 124953-48-6 4-(5-Phenyl-isoxazole-3-carbonyl)-piperazine-1-carbothioic acid (2-cyano-4,5-dimethoxy-phenyl)-amide 
• 124953-46-4 4-(3-Phenyl-isoxazole-5-carbonyl)-piperazine-1-carbothioic acid (2-cyano-4,5-dimethoxy-phenyl)-amide 
• 124953-44-2 4-(3-Methoxy-isoxazole-5-carbonyl)-piperazine-1-carbothioic acid (2-cyano-4,5-dimethoxy-phenyl)-amide 
• 124953-42-0 4-(3-Bromo-isoxazole-5-carbonyl)-piperazine-1-carbothioic acid (2-cyano-4,5-dimethoxy-phenyl)-amide 
• 124953-43-1 4-(3-Chloro-isoxazole-5-carbonyl)-piperazine-1-carbothioic acid (2-cyano-4,5-dimethoxy-phenyl)-amide 
• 124953-37-3 (3-Phenyl-isoxazol-5-yl)-piperazin-1-yl-methanone 
• 124953-39-5 (5-phenylisoxazol-3-yl)(piperazin-1-yl)methanone 

Relevant articles and documents

OXAZOLIDINONE ANTIBIOTICS

The invention relates to compounds of formula (I) wherein U, V, W, X, R1, R2, R3, R4, R5, R6, A, B, D, E, G, m and n are as defined in the description, to pharmaceutically acceptable salts of such compounds for use in the manufacture of a medicament for the prevention or treatment of a bacterial infection. Certain compounds of formula (I) are new and are also part of this invention.

ANTIHYPERTENSIVE QUINAZOLINE DERIVATIVES

Novel quinazoline compounds and antihypertensive compositions containing said compounds are disclosed; said compounds having the formula: STR1 wherein R 1 is a hydrogen atom or an alkyl group having 1-5 carbon atoms;R 2 is a group of the formula STR2 in which Y is a hydrogen atom, an alkyl group of 1-5 carbon atoms, an alkoxy group of 1-5 carbon atoms, an alkenyloxy group, a methylenedioxy group, a nitro group, a halogen atom, a trifluoromethyl group, an acyloxy group, a hydroxy group, an unsubstituted or substituted amino group or a condensed benzene nucleus and m is an integer of 1-3 inclusive, or a group of the formula STR3 in which X is an oxygen atom, a sulfur atom or a carbon-nitrogen double bond and Z is a hydrogen atom, an alkyl group of 1-5 carbon atoms, an alkoxy group of 1-5 carbon atoms, a nitro group or a halogen atom; and n is an integer of 2-3 inclusive;provided that, when R 2 is the said group STR4 n is 2 and R 1 is a hydrogen atom or, when R 2 is the said group STR5 n is 2 or 3 and R 1 is a hydrogen atom or the said alkyl group and a pharmaceutically acceptable acid addition salt thereof.